Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP271566.RA8NNJi76YNwpGunqEqEpjFD-mk30GYN22yCbMGQ7q-Cg130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP271566.RA8NNJi76YNwpGunqEqEpjFD-mk30GYN22yCbMGQ7q-Cg130_provenance.
• NP187365.RA0P7SxCxhOcu6u55QDab3W71wkPwu9bMu1D26ZxrvN14130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187365.RA0P7SxCxhOcu6u55QDab3W71wkPwu9bMu1D26ZxrvN14130_provenance.
• assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP72630.RAZLy6eJtHPDGVM-Jn0n8qJw3wEW2qISQ8Vb3UO5wnHlY130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP72630.RAZLy6eJtHPDGVM-Jn0n8qJw3wEW2qISQ8Vb3UO5wnHlY130_provenance.
• assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP547539.RADX41GsuH1yMRZX_JcdCnY9r39vGJwWiEZ8KI4dk74Zo130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547539.RADX41GsuH1yMRZX_JcdCnY9r39vGJwWiEZ8KI4dk74Zo130_provenance.
• NP344997.RAuXtgAl14Nn7XNidDxzNKEMzbvHocQqLbdPaE2aXZ9Mw130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344997.RAuXtgAl14Nn7XNidDxzNKEMzbvHocQqLbdPaE2aXZ9Mw130_provenance.
• NP547536.RAig0uiYi2mHO1-eznWO66owZm63tK0mU76FWL1ljKvIM130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547536.RAig0uiYi2mHO1-eznWO66owZm63tK0mU76FWL1ljKvIM130_provenance.
• NP547541.RAkYCcMrITpVz-ChNAxK7rFLXiBNSTiSE0Zw018omWCGQ130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547541.RAkYCcMrITpVz-ChNAxK7rFLXiBNSTiSE0Zw018omWCGQ130_provenance.
• NP481922.RA2vHY_9wf-FBav3XMJMeETHnLOmgtIKJMOUfXy7f8TmI130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481922.RA2vHY_9wf-FBav3XMJMeETHnLOmgtIKJMOUfXy7f8TmI130_provenance.
• NP345048.RAz1EPqxvve48hddkp8e0lkDWMHzijo_MIprZdf9gSnew130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345048.RAz1EPqxvve48hddkp8e0lkDWMHzijo_MIprZdf9gSnew130_provenance.
• NP547535.RAL2rdtgQylskf2MYTv63hV2ZmatfTM-Wo86bl2V1XlPw130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547535.RAL2rdtgQylskf2MYTv63hV2ZmatfTM-Wo86bl2V1XlPw130_provenance.
• NP547540.RAHQmSZ2BZ3FNcnTZGDniYp0XS1lj2C35d7Vmpjb3Dsz8130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547540.RAHQmSZ2BZ3FNcnTZGDniYp0XS1lj2C35d7Vmpjb3Dsz8130_provenance.
• NP100351.RA16jSwio12kye9Sv5d77FaUTURzB1eVF_XQpHtUzLNaU130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100351.RA16jSwio12kye9Sv5d77FaUTURzB1eVF_XQpHtUzLNaU130_provenance.
• NP547538.RA0if757vyINoJlgSoLEVdK46vE-twsp98tDGvswHyu0c130_assertion description "[The IGF-I (CA) repeat and CYP19 (TTTA) repeat polymorphisms may be novel predictors in prostate cancer patients with bone metastasis at the diagnosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547538.RA0if757vyINoJlgSoLEVdK46vE-twsp98tDGvswHyu0c130_provenance.